Midazolam inhibits proinflammatory mediators in the lipopolysaccharide- activated macrophage

Anesthesiology

Volumn 105, Issue 1, 2006, Pages 105-110

  Kim, Seon Nyo ^a   Son, Soo Chang ^a   Lee, Sang Mook ^b   Kim, Cuk Seong ^a   Yoo, Dae Goon ^a   Lee, Sang Ki ^a   Hur, Gang Min ^a   Park, Jin Bong ^a   Jeon, Byeong Hwa ^a  

^a Chungnam National University   (South Korea)

^b The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MIDAZOLAM; MITOGEN ACTIVATED PROTEIN KINASE; SYNAPTOTAGMIN; AUTACOID;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CELL CULTURE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; EVALUATION; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; IMMUNOCYTOCHEMISTRY; MACROPHAGE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; ANIMAL; CELL LINE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ANTAGONISM; MACROPHAGE; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MIDAZOLAM; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B;

EID: 33746932119     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/00000542-200607000-00019     Document Type: Article

References (39)

1. Karima R, Matsumoto S, Higashi H, Matsushima K: The molecular pathogenesis of endotoxic shock and organ failure. Mol Med Today 1999; 5:123-32
2. Johnson D, Mayers I: Multiple organ dysfunction syndrome: a narrative review. Can J Anaesth 2001; 48:502-9
3. Raetz CR, Ulevitch RJ, Wright SD, Sibley CH, Ding A, Nathan CF: Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J 1991; 5:2652-60
4. West MA, Li MH, Seatter SC, Bubrick MP: Pre-exposure to hypoxia or septic stimuli differentially regulates endotoxin release of tumor necrosis factor, interleukin-6, interleukin-1, prostaglandin E2, nitric oxide, and superoxide by macrophages. J Trauma 1994; 37: 82-9; discussion 89-90
5. West MA, Seatter SC, Bellingham J, Clair L: Mechanisms of reprogrammed macrophage endotoxin signal transduction after lipopolysaccharide pretreatment. Surgery 1995; 118:220-8
6. Chang H, Tsai SY, Chang Y, Chen TL, Chen RM: Therapeutic concentrations of propofol protects mouse macrophages from nitric oxide-induced cell death and apoptosis. Can J Anaesth 2002; 49:477-80
7. Hempel SL, Monick MM, Hunninghake GW: Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. J Clin Invest 1994; 93:391-6
8. Hla T, Ristimaki A, Appleby S, Barriocanal JG: Cyclooxygenase gene expression in inflammation and angiogenesis. Ann N Y Acad Sci 1993; 696:197-204
9. Zavala F, Haumont J, Lenfant M: Interaction of benzodiazepines with mouse macrophages. Eur J Pharmacol 1984; 106:561-6
10. Awad M, Gavish M: Peripheral-type benzodiazepine receptors in human cerebral cortex, kidney, and colon. Life Sci 1991; 49:1155-61
11. Wilms H, Claasen J, Rohl C, Sievers J, Deuschl G, Lucius R: Involvement of benzodiazepine receptors in neuroinflammatory and neurodegenerative diseases: evidence from activated microglial cells in vitro. Neurobiol Dis 2003; 14:417-24
12. Taupin V, Jayais P, Descamps-Latscha B, Cazalaa JB, Barrier G, Bach JF, Zavala F: Benzodiazepine anesthesia in humans modulates the interleukin-1 beta, tumor necrosis factor-alpha and interleukin-6 responses of blood monocytes. J Neuroimmunol 1991; 35:13-9
13. Bidri M, Royer B, Averlant G, Bismuth G, Guillosson JJ, Arock M: Inhibition of mouse mast cell proliferation and proinflammatory mediator release by benzodiazepines. Immunopharmacology 1999; 43:75-86
14. Rossano F, Tufano R, Cipollaro de L'Ero G, Servillo G, Baroni A, Tufano MA: Anesthetic agents induce human mononuclear leucocytes to release cytokines. Immunopharmacol Immunotoxicol 1992; 14:439-50
15. Raschke WC, Baird S, Ralph P, Nakoinz I: Functional macrophage cell lines transformed by Abelson leukemia virus. Cell 1978; 15:261-7
16. Miyawaki T, Sogawa N, Maeda S, Kohjitani A, Shimada M: Effect of midazolam on interleukin-6 mRNA expression in human peripheral blood mononuclear cells in the absence of lipopolysaccharide. Cytokine 2001; 15:320-7
17. Jeon BH, Gupta G, Park YC, Qi B, Haile A, Khanday FA, Liu YX, Kim JM, Ozaki M, White AR, Berkowitz DE, Irani K: Apurinic/apyrimidinic endonuclease 1 regulates endothelial NO production and vascular tone. Circ Res 2004; 95:902-10
18. Kim CS, Park JB, Kim KJ, Chang SJ, Ryoo SW, Jeon BH: Effect of Korea red ginseng on cerebral blood flow and superoxide production. Acta Pharmacol Sin 2002; 23:1152-6
19. Skatchkov MP, Sperling D, Hink U, Mulsch A, Harrison DG, Sindermann I, Meinertz T, Munzel T: Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide production. Biochem Biophys Res Commun 1999; 254:319-24
20. Smith WL, Garavito RM, DeWitt DL: Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 1996; 271:33157-60
21. Kim YM, Lee BS, Yi KY, Paik SG: Upstream NF-kappaB site is required for the maximal expression of mouse inducible nitric oxide synthase gene in interferon-gamma plus lipopolysaccharide-induced RAW 264.7 macrophages. Biochem Biophys Res Commun 1997; 236:655-60
22. Ulevitch RJ, Tobias PS: Recognition of gram-negative bacteria and endotoxin by the innate immune system. Curr Opin Immunol 1999; 11:19-22
23. Sanghera JS, Weinstein SL, Aluwalia M, Girn J, Pelech SL: Activation of multiple proline-directed kinases by bacterial lipopolysaccharide in murine macrophages. J Immunol 1996; 156:4457-65
24. Chen Z, Hagler J, Palombella VJ, Melandri F, Scherer D, Ballard D, Maniatis T: Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev 1995; 9:1586-97
25. Krappmann D, Wegener E, Sunami Y, Esen M, Thiel A, Mordmuller B, Scheidereit C: The IkappaB kinase complex and NF-kappaB act as master regulators of lipopolysaccharide-induced gene expression and control subordinate activation of AP-1. Mol Cell Biol 2004; 24:6488-500
26. Bowling AC, DeLorenzo RJ: Micromolar affinity benzodiazepine receptors: identification and characterization in central nervous system. Science 1982; 216:1247-50
27. Baeuerle PA, Henkel T: Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994; 12:141-79
28. Newton R, Kuitert LM, Bergmann M, Adcock IM, Barnes PJ: Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta. Biochem Biophys Res Commun 1997; 237:28-32
29. Xie QW, Kashiwabara Y, Nathan C: Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 1994; 269:4705-8
30. Hwang D, Jang BC, Yu G, Boudreau M: Expression of mitogen-inducible cyclooxygenase induced by lipopolysaccharide: mediation through both mitogen-activated protein kinase and NF-kappaB signaling pathways in macrophages. Biochem Pharmacol 1997; 54:87-96
31. Guan Z, Buckman SY, Miller BW, Springer LD, Morrison AR: Interleukin-1beta-induced cyclooxygenase-2 expression requires activation of both c-Jun NH2-terminal kinase and p38 MAPK signal pathways in rat renal mesangial cells. J Biol Chem 1998; 273:28670-6
32. Chen BC, Chou CF, Lin WW: Pyrimidinoceptor-mediated potentiation of inducible nitric-oxide synthase induction in J774 macrophages. Role of intracellular calcium. J Biol Chem 1998; 273:29754-63
33. Tsi CJ, Chao Y, Chen CW, Lin WW: Aurintricarboxylic acid protects against cell death caused by lipopolysaccharide in macrophages by decreasing inducible nitric-oxide synthase induction via IkappaB kinase, extracellular signal-regulated kinase, and p38 mitogen-activated protein kinase inhibition. Mol Pharmacol 2002; 62:90-101
34. Ho FM, Lai CC, Huang LJ, Kuo TC, Chao CM, Lin WW: The anti-inflammatory carbazole, LCY-2-CHO, inhibits lipopolysaccharide-induced inflammatory mediator expression through inhibition of the p38 mitogen-activated protein kinase signaling pathway in macrophages. Br J Pharmacol 2004; 141:1037-47
35. Matsuda T, Omori K, Vuong T, Pascual M, Valiente L, Ferreri K, Todorov I, Kuroda Y, Smith CV, Kandeel F, Mullen Y: Inhibition of p38 pathway suppresses human islet production of pro-inflammatory cytokines and improves islet graft function. Am J Transplant 2005; 5:484-93
36. Branger J, van den Blink B, Weijer S, Madwed J, Bos CL, Gupta A, Yong CL, Polmar SH, Olszyna DP, Hack CE, van Deventer SJ, Peppelenbosch MP, van der Poll T: Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia. J Immunol 2002; 168:4070-7
37. Cuzzocrea S, Riley DP, Caputi AP, Salvemini D: Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 2001; 53:135-59
38. Haddad JJ: Redox regulation of pro-inflammatory cytokines and IkappaB-alpha/NF-kappaB nuclear translocation and activation. Biochem Biophys Res Commun 2002; 296:847-56
39. Stevenson GW, Hall SC, Rudnick S, Seleny FL, Stevenson HC: The effect of anesthetic agents on the human immune response. ANESTHESIOLOGY 1990; 72:542-52